5-18-2020Cross-posted from NIAID NewsroomNIH Study is First Large Trial to Find Long-Acting HIV Prevention Highly Effective--Companion Study in Women Is OngoingAn invest…
5-18-2020NIAID honors ongoing efforts to develop a safe, effective and durable HIV vaccine while scientists also research coronavirus disease 2019 (COVID-19).
4-23-2020As a participant in the recent virtual 2020 Conference on Retroviruses and Opportunistic Infections (CROI), I found several studies to be particularly relevant …
3-31-2020The 2020 Conference on Retroviruses and Opportunistic Infections (CROI) was convened as a virtual conference earlier this month. Each year, thousands of researc…
3-11-2020Cross-posted from NIAID NewsroomDolutegravir-containing regimen exhibited superior safety profile in large, NIH-supported study of pregnant women.The antiretrov…
3-9-2020Cross-posted from NIAID NewsroomAmong African adolescent girls and young women who took HIV pre-exposure prophylaxis (PrEP) daily, levels of the PrEP drug tenof…
3-9-2020Cross-posted from NIAID NewsroomA new approach to direct the body to make a specific antibody against HIV led to sustained production of that antibody for more …
2-25-2020Cross-posted from National Institutes of HealthLess than one in four adolescent men who have sex with men (AMSM) ever get tested for HIV, research funded by the…
2-25-2020Cross-posted from National Institutes of HealthDespite similar rates of enrollment into medical care, youth with HIV have much lower rates of viral suppression …
